Sheila Singh

Chief Executive Officer at Empirica Therapeutics, Inc.

Health Technology

Profile

Sheila Singh is the founder of Empirica Therapeutics, Inc. She currently holds the position of Independent Director at Centre For Probe Development & Commercialization.

Sheila Singh active positions

Companies	Position	Start
Empirica Therapeutics, Inc. Empirica Therapeutics, Inc. BiotechnologyHealth Technology Empirica Therapeutics, Inc. develops novel allogeneic living drugs. The company was founded by Sheila Singh and Jason Moffat in July, 2018 and is headquartered in Hamilton, Canada.	Chief Executive Officer	-
Centre For Probe Development & Commercialization Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin.	Director/Board Member	2021-06-16

All active positions of Sheila Singh

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Sheila Singh's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Centre For Probe Development & Commercialization Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin.	Health Technology
Empirica Therapeutics, Inc. Empirica Therapeutics, Inc. BiotechnologyHealth Technology Empirica Therapeutics, Inc. develops novel allogeneic living drugs. The company was founded by Sheila Singh and Jason Moffat in July, 2018 and is headquartered in Hamilton, Canada.	Health Technology